BELVIN MARCIA

CTMX

BELVIN MARCIA serves as officer: SVP, Chief Scientific Officer at CytomX Therapeutics, Inc. (CTMX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$289.0K

Net Position

Net Seller

$289.0K

Companies Traded

CTMX

Active Period

Sep 2023 – Mar 2026

6 total trades

Most Recent

Sell CTMX

Mar 19, 2026 · $202.3K

BELVIN MARCIA's Insider Trading at CytomX Therapeutics, Inc. (CTMX)

Buys

0 · $0.00

Sells

6 · $289.0K

Total Shares Bought

Total Shares Sold

85,879

CTMX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 19, 2026	Sell	31,492	$6.42	$202.3K	300,760
Jun 13, 2025	Sell	13,884	$2.69	$37.3K	0
Mar 18, 2025	Sell	19,512	$0.60	$11.7K	0
Mar 19, 2024	Sell	12,795	$2.09	$26.7K	0
Dec 20, 2023	Sell	4,077	$1.38	$5.6K	0
Sep 20, 2023	Sell	4,119	$1.30	$5.4K	0

Related Insiders

Yu-Waye Chu

officer: Chief Medical Officer

CTMXSell · Mar 19, 2026

Sean A. McCarthy

director, officer: CEO

CTMXSell · Mar 19, 2026

Christopher Ogden

officer: Chief Financial Officer

CTMXSell · Mar 19, 2026

Explore More Insider Trading Data

CTMX Insider Trading Activity

View all insider trades at CytomX Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity